You have 9 free searches left this month | for more free features.

Condition

Alzheimers Disease (2)

Alzheimer's Disease (1)

Substance Abuse (1)

Substance Use (1)

Substance Use Disorders (1)

Overall Status

Terminated (2)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2/phase 3 (2)

n/a (1)

phase 2 (1)

Sponsor

Novartis Pharmaceuticals (3)

University of Arizona (1)

Collaborator

Amgen (2)

Banner Alzheimer's Institute (2)

National Institute on Aging (NIA) (1)

Study Documents

Intervention Type

drug (3)

other (2)

biological (1)

device (1)

Funder Type

Industry (3)

Other (1)

Study Type

Interventional (4)

CNP520

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Alzheimers Disease Trial in Worldwide (biological, other, drug)

Terminated

Has Results

Alzheimers Disease

CAD106 Immunotherapy
+4 more

Phoenix, Arizona
+128 more

Jul 7, 2021

Alzheimers Disease Trial in Worldwide (CNP520 50mg, CNP520 15mg, Matching )

Terminated

Has Results

Alzheimers Disease

CNP520 50mg
+2 more

Phoenix, Arizona
+193 more

Aug 4, 2021

Substance Use Disorders, Substance Abuse, Substance Use Trial in Tucson (tDCS, tDCS Sham)

Recruiting

Substance Use Disorders
+2 more

tDCS
tDCS Sham

Tucson, Arizona

Allison J. Huff

May 2, 2023

Alzheimer's Disease Trial in Worldwide (CNP520, Placebo)

Completed

Has Results

Alzheimer's Disease

CNP520
Placebo

Glendale, California
+10 more

Aug 7, 2017